menu search

PRTK / Paratek Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference

Paratek Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
BOSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today announces that Evan Loh, M.D., chief executive officer, will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Wednesday, Nov. 30 at 9:15 a.m. ET. Read More
Posted: Nov 21 2022, 16:05
Author Name: GlobeNewsWire
Views: 102836

PRTK News  

Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 16

By GlobeNewsWire
March 8, 2023

Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 16

BOSTON, March 08, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call a more_horizontal

Paratek Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference

By GlobeNewsWire
November 21, 2022

Paratek Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference

BOSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the de more_horizontal

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
August 3, 2022

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q2 2022 Results - Earnings Call Transcript

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Sarah Higgins - VP, Contr more_horizontal

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 4, 2022

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2022 Results - Earnings Call Transcript

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Evan Loh - CEO Sarah Higgins more_horizontal

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 14, 2022

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call Transcript

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: